Form 8-K Filing for Co-Diagnostics, Inc.

Co-Diagnostics, Inc. filed a Form 8-K on September 16, 2026, to disclose information regarding an upcoming investor and analyst presentation. The presentation will cover the company's collaboration with ReadyGo Diagnostics Ltd., its Co-Dx PCR platform, development activities, manufacturing initiatives, and operations in India. The presentation materials are attached as Exhibit 99.1 to the filing. This information is furnished under Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act.